Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
09/1997
09/17/1997EP0794792A1 Method of promoting an immune response with a bispecific antibody
09/17/1997EP0794775A1 Green porphyrins as immunomodulators
09/17/1997EP0755675B1 Dermatological and/or pharmaceutical composition, process of preparation and utilization
09/17/1997EP0590060B1 Orally administrable therapeutic proteins and method of making
09/17/1997CN1159830A Immunomodulators
09/17/1997CN1159811A Isolated nucleic acid molecule coding for tumor rejection antigen precursor dage and uses thereof
09/17/1997CN1159804A Dihydrobenzofuranes
09/17/1997CN1159759A Compositions containing tumor rejection antigen precursors or tumor rejection antigens, and an adjuvant and/or growth factor
09/17/1997CN1159330A Traditional Chinese medicine ointment for AIDS
09/17/1997CN1035876C Tetrahydrothiophene derivatives and medicine composition thereof
09/16/1997US5668150 Antiallergy, antiinflammatory
09/16/1997US5668132 HIV Protease inhibitors useful for the treatment of AIDS
09/16/1997US5668115 Hydrolyzates of colominic acid
09/16/1997US5667777 Gene therapy for treatment of glomerular kidney disease, expression of beta-galactosidase
09/12/1997WO1997032992A1 Immortalized hematopoietic cell lines, cell system thereof with stromal cells, in vitro, ex vivo and in vivo uses, and in vitro generation of dendritic cells and macrophages
09/12/1997WO1997032989A2 Recombinant aav vector-based transduction system and use of same
09/12/1997WO1997032988A1 Adeno-associated virus vector for boosting immunogenicity of cells
09/12/1997WO1997032896A1 Antitumor substance extracted from hen-of-the-woods
09/12/1997WO1997032882A1 PYRIMIDO[5,4-d]PYRIMIDINES, MEDICAMENTS CONTAINING THESE COMPOUNDS, THEIR USE AND PROCESS FOR THEIR PRODUCTION
09/12/1997WO1997032881A1 4-amino pyrimidine derivates, medicaments containing these compounds, their use and process for their production
09/12/1997WO1997032880A1 Pyrimido[5,4-d]pyrimidines, medicaments containing these compounds, their use and process for their production
09/12/1997WO1997032865A1 Novel aryl glycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds
09/12/1997WO1997032844A1 Hydroxyamidino derivatives useful as nitric oxide synthase inhibitors
09/12/1997WO1997032600A1 Peptide-base immunotherapeutic agent for allergic diseases
09/12/1997WO1997032598A2 Vaccines
09/12/1997WO1997032586A1 Caffeine and clemastine for treating respiratory disorders
09/12/1997WO1997032575A1 Mercapto derivatives as inhibitors of cyclooxygenases
09/12/1997WO1997021826A3 Complementary adenoviral vector systems and cell lines
09/12/1997WO1997004097A3 Human CTLA-8 and uses of CTLA-8-related proteins
09/12/1997CA2248720A1 Pyrimido[5,4-d]pyrimidines, pharmaceuticals containing these compounds, their use and processes for the preparation thereof
09/12/1997CA2248555A1 Immortalized hematopoietic cell lines, cell system thereof with stromal cells, in vitro, ex vivo and in vivo uses, and in vitro generation of dendritic cells and macrophages
09/12/1997CA2248316A1 Pyrimido[5,4-d]pyrimidines, pharmaceuticals containing these compounds, their use and processes for their preparation
09/12/1997CA2247500A1 Caffeine and clemastine for treating respiratory disorders
09/12/1997CA2243994A1 4-amino pyrimidine derivates, medicaments containing these compounds, their use and process for their production
09/11/1997DE19608751A1 Adeno-assoziierter Virus-Vektor zur Steigerung der Immunogenität von Zellen Adeno-associated virus vector for enhancing the immunogenicity of cells
09/11/1997DE19608665A1 Neue Arylglycinamidderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen New Arylglycinamidderivate, processes for their preparation containing these compounds and pharmaceutical compositions
09/11/1997DE19608653A1 Pyrimido[5,4-d]pyrimidine, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung Pyrimido [5,4-d] pyrimidines, medicaments containing these compounds, their use and process for their preparation
09/11/1997DE19608588A1 Pyrimido [5,4-d]pyrimidine, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung Pyrimido [5,4-d] pyrimidines, medicaments containing these compounds, their use and process for their preparation
09/10/1997EP0793966A1 Cyclosporin-containing topical pharmaceutical composition
09/10/1997EP0793717A1 Oral immunization with transgenic plants
09/10/1997EP0793641A1 Metalloproteinase inhibitors
09/10/1997EP0793500A1 Pharmaceutical compositions comprising nitric oxide-releasing biopolymers
09/10/1997EP0699073A4 Allogeneic and xenogeneic transplantation
09/10/1997EP0689454B1 Vaccine compositions containing 3-o deacylated monophosphoryl lipid a
09/10/1997EP0669001B1 Determination of peptide motifs on mhc molecules
09/10/1997EP0640070B1 Styryl derivatives, their preparation and use as pde-iv inhibitors
09/10/1997EP0566644B1 Method of removing endotoxins
09/10/1997CN1159196A Inhibitors of interleukin-1'beta' converting enzyme
09/10/1997CN1158856A Peptide capable of inducing immune response to human gastric cancer and agent for preventing or treating human gastric cancer, containing the peptide
09/10/1997CN1158726A Process for making pharmaceutical formulation containing novel steroid esters
09/10/1997CN1158725A Use of 8,9-dehydroestrone as antioxidant
09/09/1997US5665886 Neurokinin receptor antagonists
09/09/1997US5665883 Treatment of pain, inflammation, migraine, emesis
09/09/1997US5665873 Inhibits reactivation of herpes virus
09/09/1997US5665863 Coupled to albumin; genetic engineering
09/09/1997US5665774 Treatment of autoimmune diseases
09/09/1997US5665772 O-alkylated rapamycin derivatives and their use, particularly as immunosuppressants
09/09/1997US5665768 Heteroaryl cycloalkenyl hydroxyureas
09/09/1997US5665761 Infusion of less than 6 hours
09/09/1997US5665749 For treating inflammation, allergies or cardiovascular diseases in mammals
09/09/1997US5665737 Phosphodiesterase inhibitors
09/09/1997US5665735 Antiasthmatic, antiallergic, antiinflammatory agents
09/09/1997US5665548 Characterization and detection of sequences associated with autoimmune diseases
09/09/1997US5665380 Lipid vesicle fusion as a method of transmitting a biologically active material to a cell
09/09/1997US5665356 Human anti-Rh (D) monoclonal antibodies
09/09/1997CA2014521C 2-substituted n,n'-ditrimethoxybenzoyl piperazines, a preparation process of the same and therapeutic compositions containing them
09/04/1997WO1997032029A1 Parapoxviruses containing foreign dna, their production and their use in vaccines
09/04/1997WO1997032008A1 Conjugated linoleic acids for attenuating the allergic response
09/04/1997WO1997031949A1 Antibodies binding to monocyte chemoattractant protein 1 (mcp-1) receptor (ccr2)
09/04/1997WO1997031948A1 Peptide immunogens for vaccination against and treatment of allergy
09/04/1997WO1997031944A1 Fragments of cr1 and their use
09/04/1997WO1997031921A1 Immunosuppressive compounds and methods
09/04/1997WO1997031920A1 Immunosuppressive compounds and methods
09/04/1997WO1997031899A1 Synthetic derivatives of rapamycin as multimerising agents for chimeric proteins with immunophilin derived domains
09/04/1997WO1997031898A1 Synthetic derivatives of rapamycin as multimerizing agents for chimeric proteins with immunophilin-derived domains
09/04/1997WO1997031895A2 Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
09/04/1997WO1997031648A1 Use of il-7 for treating auto-immune diseases and insulin-dependent diabetes mellitus in particular
09/04/1997WO1997031634A1 At1 receptor antagonist for the stimulation of apoptosis
09/04/1997WO1997022699A3 Murine monoclonal anti-idiotype antibody 11d10 an methods of use thereof
09/04/1997CA2247208A1 Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
09/03/1997EP0792642A1 Method of treating conditions with estrogen agonists
09/03/1997EP0792641A1 Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions
09/03/1997EP0792640A2 Use of (E)-1-(4'-(2-alkylaminoethioxy)-phenyl)-1-(3'-hydroxyphenyl)-2-phenylbut-1-enes for inhibiting pathological conditions
09/03/1997EP0792370A1 INTERLEUKIN-1 $g(b) CONVERTING ENZYME LIKE APOPTOSIS PROTEASE-3 AND 4
09/03/1997EP0792354A1 Targeted t lymphocytes
09/03/1997EP0792347A1 Methods for producing enhanced antigenic helicobacter sp. and vaccines comprising same
09/03/1997EP0792294A1 Human antibodies to t-cell receptor peptides and methods for their preparation
09/03/1997EP0792288A1 Conjugates of bdnf and nt-3 with a water-soluble polymer
09/03/1997EP0792287A1 Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein
09/03/1997EP0792286A1 Methods for treatment of multiple sclerosis using peptide analogues at position 91 of human myelin basic protein
09/03/1997EP0792157A1 Preparation of mhc-peptide complexes
09/03/1997CN1158612A Novel substituted piperidines useful for the treatment of allergic diseases
09/02/1997US5663412 Antihistamines
09/02/1997US5663381 Process for preparing form 1 ranitidine hydrochloride
09/02/1997US5663380 Cysteine protease inhibitors containing heterocyclic leaving groups
09/02/1997US5663375 Cell proliferation
09/02/1997US5663364 Heme binding compounds and use thereof
09/02/1997US5663347 Regulators of cell proliferation and differentiation; treatment of skin disorders; anticarcinognic agents
09/02/1997US5663345 Immunoregulatory, neuromuscular, joint and connective tissue disorders
09/02/1997US5663335 Antiinflammatory agents; treatment of rheumatoid arthritis